Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 24, 2021 Filed Jun 28, 2021 21:22 UTC |
Isacson OleDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.97 | $0.00 |
DisclosureSEC source: 0001140361-21-022575 · form4.xml · derivative · entry 1 Isacson Ole · CIK 0001772001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: . The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date Read SEC document |
| June 24, 2021 Filed Jun 28, 2021 21:17 UTC |
Churchwell KevinDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $3.97 | $0.00 |
DisclosureSEC source: 0001140361-21-022569 · form4.xml · derivative · entry 1 Churchwell Kevin · CIK 0001771984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2031-06-24 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:36 UTC |
MCGUIRE TERRANCEDirector
|
PurchaseCommon Stock | 3,322 | $3.12 | $10,364.64 |
DisclosureSEC source: 0000899243-21-022327 · doc4.xml · nonDerivative · entry 2 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Entrepreneurs' Fund VIII, L.P. Disclosed balance after: 24,957 F1 · shares: On June 3, 2021, Polaris Partners VIII, L.P. ("PP VIII") and Polaris Entrepreneurs' Fund VIII, L.P. ("PEF VIII") agreed to purchase directly from the Issuer such shares of Common Stock of the Issuer in a private placement transaction. F3 · ownership.nature: The reportable securities are owned directly by PEF VIII. PPGP VIII is the general partner of PEF VIII. The Reporting Person, a member of the Issuer's Board of Directors, is an interest holder of PPGP VIII. Each of the Reporting Person and the Managing Members, in their respective capacities with respect to PPGP VIII, may be deemed to have shared voting and dispositive power over the shares held by PEF VIII. Each of PPGP VIII, the Reporting Person and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:36 UTC |
MCGUIRE TERRANCEDirector
|
PurchaseCommon Stock | 92,831 | $3.12 | $289,632.72 |
DisclosureSEC source: 0000899243-21-022327 · doc4.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Partners VIII, L.P. Disclosed balance after: 697,313 F1 · shares: On June 3, 2021, Polaris Partners VIII, L.P. ("PP VIII") and Polaris Entrepreneurs' Fund VIII, L.P. ("PEF VIII") agreed to purchase directly from the Issuer such shares of Common Stock of the Issuer in a private placement transaction. F2 · ownership.nature: The reportable securities are owned directly by PP VIII. Polaris Partners GP VIII, L.L.C. ("PPGP VIII") is the general partner of PP VIII. The Reporting Person, a member of the Issuer's Board of Directors, is an interest holder of PPGP VIII. Each of David Barrett, Brian Chee, Amir Nashat and Bryce Youngren are the managing members of PPGP VIII (collectively, the "Managing Members"). Each of the Reporting Person and the Managing Members, in their respective capacities with respect to PPGP VIII, may be deemed to have shared voting and dispositive power over the shares held by PP VIII. Each of PPGP VIII, the Reporting Person and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 21:25 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
PurchaseCommon Stock | 823,170 | $3.28 | $2,699,997.60 |
DisclosureSEC source: 0001140361-21-020090 · form4.xml · nonDerivative · entry 1 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,047,698 F1 · shares: On June 3, 2021, the reporting person agreed to purchase directly from the Issuer 823,170 shares of Common Stock of the Issuer in a private placement transaction. Read SEC document |
| June 03, 2021 Filed Jun 7, 2021 20:05 UTC |
Slate Path Capital LP10% owner
Greenspan David Gerald10% owner
|
PurchaseCommon Stock, no par value | 961,538 | $3.12 | $2,999,998.56 |
DisclosureSEC source: 0000902664-21-003032 · ownership.xml · nonDerivative · entry 1 Slate Path Capital LP · CIK 0001559706 · 10% owner Greenspan David Gerald · CIK 0001820641 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,157,601 F1 · ownership.nature: The securities to which this filing relates are held by Slate Path Master Fund LP (the "Master Fund"), a Cayman Islands exempted limited partnership. Slate Path Capital LP (the "Investment Manager"), a Delaware limited partnership acts as the investment manager of the Master Fund. Mr. David Greenspan serves as the managing member of Jades GP, LLC, a Delaware limited liability company and the general partner of the Investment Manager. The filing of this statement shall not be deemed an admission that either Reporting Person is the beneficial owner of the securities reported herein for purposes of Section 16 of the Securities Act of 1934, as amended, or otherwise. Each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest therein. Read SEC document |
| May 06, 2021 Filed May 10, 2021 12:45 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
PurchaseCommon Stock | 302,000 | $2.43 | $733,860.00 |
DisclosureSEC source: 0001140361-21-016532 · form4.xml · nonDerivative · entry 1 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,224,528 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.31 to $2.59, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| May 05, 2021 Filed May 7, 2021 01:27 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
PurchaseCommon Stock | 398,001 | $2.53 | $1,006,942.53 |
DisclosureSEC source: 0001140361-21-016304 · form4.xml · nonDerivative · entry 2 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 922,528 F2 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.32 to $2.61, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| May 04, 2021 Filed May 7, 2021 01:27 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
PurchaseCommon Stock | 300,000 | $2.29 | $687,000.00 |
DisclosureSEC source: 0001140361-21-016304 · form4.xml · nonDerivative · entry 1 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 524,527 F1 · price: The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.10 to $2.45, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:23 UTC |
Gjino AnjezaChief Financial Officer
|
SaleCommon Stock | 1,824 | $4.00 | $7,296.00 |
DisclosureSEC source: 0001140361-21-006649 · form4.xml · nonDerivative · entry 1 Gjino Anjeza · CIK 0001839068 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,599 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $4.00, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| February 25, 2021 Filed Mar 1, 2021 21:17 UTC |
Wright Christopher IChief Medical Officer
|
SaleCommon Stock | 2,637 | $3.99 | $10,521.63 |
DisclosureSEC source: 0001140361-21-006641 · form4.xml · nonDerivative · entry 1 Wright Christopher I · CIK 0001838503 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,728 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.80 to $4.00, inclusive. The reporting person will provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in this footnote. Read SEC document |
| December 28, 2020 Filed Dec 30, 2020 18:14 UTC |
Currie Mark GPresident and CSO
|
SaleCommon Stock | 20,107 | $3.01 | $60,522.07 |
DisclosureSEC source: 0001140361-20-029869 · form4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · President and CSO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 251,648 F1 · shares: The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.94 to $3.07, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 09, 2020 Filed Nov 12, 2020 22:05 UTC |
Busch AndreasChief Innovation Officer
|
PurchaseCommon Stock | 125,000 | $2.53 | $316,250.00 |
DisclosureSEC source: 0001209191-20-058031 · doc4.xml · nonDerivative · entry 1 Busch Andreas · CIK 0001775029 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 254,704 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.48 to $2.60, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. F2 · balance_after: The reporting person acquired 2,204 and 2,500 shares of Common Stock under the issuer's employee stock purchase plan on November 29, 2019 and May 29, 2020, respectively. Read SEC document |
| November 06, 2020 Filed Nov 10, 2020 19:07 UTC |
Huyett WilliamChief Financial Officer
|
SaleCommon Stock | 3,827 | $2.52 | $9,644.04 |
DisclosureSEC source: 0001209191-20-057768 · doc4.xml · nonDerivative · entry 1 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,590 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019. Read SEC document |
| November 04, 2020 Filed Nov 6, 2020 21:43 UTC |
Busch AndreasChief Innovation Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.48 | $0.00 |
DisclosureSEC source: 0001209191-20-057302 · doc4.xml · derivative · entry 1 Busch Andreas · CIK 0001775029 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2030-11-04 F1 · derivative.exercise_date: The Option vests as to 2.08333% of the shares of Common Stock on each monthly anniversary of November 4, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 16:22 UTC |
CONRADES GEORGE HDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037587 · doc4.xml · derivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:16 UTC |
MCGUIRE TERRANCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037571 · doc4.xml · derivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:15 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037566 · doc4.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 16:18 UTC |
Fanucci MarshaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037580 · doc4.xml · derivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:16 UTC |
Mendelsohn MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037568 · doc4.xml · derivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:23 UTC |
Churchwell KevinDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037589 · doc4.xml · derivative · entry 1 Churchwell Kevin · CIK 0001771984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:17 UTC |
Isacson OleDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037575 · doc4.xml · derivative · entry 1 Isacson Ole · CIK 0001772001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 20:17 UTC |
Lovell StephanieDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $4.46 | $0.00 |
DisclosureSEC source: 0001209191-20-037573 · doc4.xml · derivative · entry 1 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2030-06-16 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| March 31, 2020 Filed Apr 2, 2020 20:59 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 153,846 | $2.65 Strike: $2.65 | $407,691.90 |
DisclosureSEC source: 0001209191-20-022657 · doc4.xml · derivative · entry 5 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 153,846 Underlying: Common Stock · 153,846 shares Expires 2030-03-31 F3 · shares: The Compensation Committee approved the stock option award to the reporting person in order to offset his low-to-market total cash compensation and provide him with a market-aligned total compensation package for 2019, 2020, and 2021. 36,436 options under the award are intended to offset his below-market total cash salary for 2019, and 58,705 options under the award are intended to offset his below-market total cash compensation for each of 2020 and 2021. F4 · derivative.exercise_date: The options, granted as an annual performance award, vests in seventy-two equal monthly installments over a six year period on each monthly anniversary of January 1, 2020 until fully vested. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 16:11 UTC |
Huyett WilliamChief Financial Officer
|
SaleCommon Stock | 3,559 | $5.12 | $18,222.08 |
DisclosureSEC source: 0001209191-20-012430 · doc4.xml · nonDerivative · entry 1 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,417 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.12 to $5.25, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 30, 2019 Filed Dec 31, 2019 22:55 UTC |
Currie Mark GPresident
|
SaleCommon Stock | 25,000 | $2.48 | $62,000.00 |
DisclosureSEC source: 0001209191-19-062322 · doc4.xml · nonDerivative · entry 2 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 271,755 F1 · shares: The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.38 to $2.60, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 27, 2019 Filed Dec 31, 2019 22:55 UTC |
Currie Mark GPresident
|
SaleCommon Stock | 25,000 | $2.55 | $63,750.00 |
DisclosureSEC source: 0001209191-19-062322 · doc4.xml · nonDerivative · entry 1 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 296,755 F1 · shares: The proceeds from the sale are intended to cover income taxes arising out of prior stock option exercises, including those in which the reporting person held the underlying shares. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.58, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 22:43 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001209191-19-058165 · doc4.xml · derivative · entry 1 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-11-22 F1 · derivative.exercise_date: The stock option grant will vest and become exercisable upon the attainment of both performance-based and service-based hurdles, as follows: (i) 20% of the shares subject to the option, if the average closing price of the common stock reported by Nasdaq for any thirty (30) consecutive trading days equals or exceeds $10; plus an additional (ii) 40% of the shares, if the average closing price equals or exceeds $20; plus an additional (iii) 40% of the shares, if the average closing price equals or exceeds $30; in each case, subject to the continuous employment or service through the later of the date that the performance hurdles set forth above are attained (but no later than December 31, 2024) and December 31, 2021. F2 · derivative.expiration_date: To the extent unvested as of December 31, 2024, all unvested shares underlying such performance-based option will be cancelled. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 22:43 UTC |
Currie Mark GPresident
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001209191-19-058163 · doc4.xml · derivative · entry 1 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-11-22 F1 · derivative.exercise_date: The stock option grant will vest and become exercisable upon the attainment of both performance-based and service-based hurdles, as follows: (i) 20% of the shares subject to the option, if the average closing price of the common stock reported by Nasdaq for any thirty (30) consecutive trading days equals or exceeds $10; plus an additional (ii) 40% of the shares, if the average closing price equals or exceeds $20; plus an additional (iii) 40% of the shares, if the average closing price equals or exceeds $30; in each case, subject to the continuous employment or service through the later of the date that the performance hurdles set forth above are attained (but no later than December 31, 2024) and December 31, 2021. F2 · derivative.expiration_date: To the extent unvested as of December 31, 2024, all unvested shares underlying such performance-based option will be cancelled. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 17:42 UTC |
Huyett WilliamChief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001209191-19-058162 · doc4.xml · derivative · entry 1 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-11-22 F1 · derivative.exercise_date: The stock option grant will vest and become exercisable upon the attainment of both performance-based and service-based hurdles, as follows: (i) 20% of the shares subject to the option, if the average closing price of the common stock reported by Nasdaq for any thirty (30) consecutive trading days equals or exceeds $10; plus an additional (ii) 40% of the shares, if the average closing price equals or exceeds $20; plus an additional (iii) 40% of the shares, if the average closing price equals or exceeds $30; in each case, subject to the continuous employment or service through the later of the date that the performance hurdles set forth above are attained (but no later than December 31, 2024) and December 31, 2021. F2 · derivative.expiration_date: To the extent unvested as of December 31, 2024, all unvested shares underlying such performance-based option will be cancelled. Read SEC document |
| November 22, 2019 Filed Nov 26, 2019 22:41 UTC |
Busch AndreasChief Innovation Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $2.01 | $0.00 |
DisclosureSEC source: 0001209191-19-058158 · doc4.xml · derivative · entry 1 Busch Andreas · CIK 0001775029 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2029-11-22 F1 · derivative.exercise_date: The stock option grant will vest and become exercisable upon the attainment of both performance-based and service-based hurdles, as follows: (i) 20% of the shares subject to the option, if the average closing price of the common stock reported by Nasdaq for any thirty (30) consecutive trading days equals or exceeds $10; plus an additional (ii) 40% of the shares, if the average closing price equals or exceeds $20; plus an additional (iii) 40% of the shares, if the average closing price equals or exceeds $30; in each case, subject to the continuous employment or service through the later of the date that the performance hurdles set forth above are attained (but no later than December 31, 2024) and December 31, 2021. F2 · derivative.expiration_date: To the extent unvested as of December 31, 2024, all unvested shares underlying such performance-based option will be cancelled. Read SEC document |
| November 15, 2019 Filed Nov 19, 2019 21:02 UTC |
Busch AndreasChief Innovation Officer
|
PurchaseCommon Stock | 125,000 | $1.82 | $227,500.00 |
DisclosureSEC source: 0001209191-19-057112 · doc4.xml · nonDerivative · entry 1 Busch Andreas · CIK 0001775029 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 125,000 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.79 to $1.87, inclusive. The reporting person will provide to the Issuer, any security holder of the Issuer or the SEC staff, upon request, full information regarding the number of shares purchased at each price within the range. Read SEC document |
| November 08, 2019 Filed Nov 12, 2019 16:26 UTC |
Huyett WilliamChief Financial Officer
|
SaleCommon Stock | 3,922 | $2.05 | $8,040.10 |
DisclosureSEC source: 0001209191-19-056008 · doc4.xml · nonDerivative · entry 1 Huyett William · CIK 0001723846 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,976 F1 · shares: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. This sale was made to cover tax withholding obligations in connection with the vesting and settlement of approximately 25% of the reporting person's restricted stock units granted on April 1, 2019. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.05 to $2.0675, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:09 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 2,000 | $0.00 Strike: $6.04 | $0.00 |
DisclosureSEC source: 0001209191-19-041920 · doc4.xml · derivative · entry 5 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,000 shares Expires 2019-07-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 20,167 shares vests in installments upon achievement of certain regulatory and commercial milestones. The option has vested as to 2,000 shares as of the date hereof. Read SEC document |
| July 10, 2019 Filed Jul 12, 2019 20:09 UTC |
Hecht Peter MDirector · Chief Executive Officer
|
Exercise / conversionCommon Stock | 2,000 | $6.04 | $12,080.00 |
DisclosureSEC source: 0001209191-19-041920 · doc4.xml · nonDerivative · entry 1 Hecht Peter M · CIK 0001478485 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 225,192 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: This transaction represents the acquisition of common stock as a result of the exercise and hold of derivative securities reported in Table II. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 16:55 UTC |
CONRADES GEORGE HDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034371 · doc4.xml · derivative · entry 1 CONRADES GEORGE H · CIK 0001106231 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:57 UTC |
MCGUIRE TERRANCEDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034379 · doc4.xml · derivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:59 UTC |
SCHULMAN AMY WDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034383 · doc4.xml · derivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 16:56 UTC |
Fanucci MarshaDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034373 · doc4.xml · derivative · entry 1 Fanucci Marsha · CIK 0001298814 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:58 UTC |
Mendelsohn MichaelDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034382 · doc4.xml · derivative · entry 1 Mendelsohn Michael · CIK 0001591109 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:57 UTC |
Lovell StephanieDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034376 · doc4.xml · derivative · entry 1 Lovell Stephanie · CIK 0001772054 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:56 UTC |
Isacson OleDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034375 · doc4.xml · derivative · entry 1 Isacson Ole · CIK 0001772001 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| June 01, 2019 Filed Jun 4, 2019 20:55 UTC |
Churchwell KevinDirector
|
GrantStock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $13.95 | $0.00 |
DisclosureSEC source: 0001209191-19-034369 · doc4.xml · derivative · entry 1 Churchwell Kevin · CIK 0001771984 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Common Stock · 10,000 shares Expires 2029-06-01 F1 · derivative.exercise_date: The options, granted pursuant to the director compensation plan, will vest in full on the first anniversary of the grant date. Read SEC document |
| April 29, 2019 Filed May 1, 2019 21:18 UTC |
Busch AndreasChief Innovation Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 300,000 | $0.00 Strike: $15.40 | $0.00 |
DisclosureSEC source: 0001209191-19-026820 · doc4.xml · derivative · entry 1 Busch Andreas · CIK 0001775029 · Chief Innovation Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 300,000 shares Expires 2029-04-29 F1 · derivative.exercise_date: The option, granted as a new hire award, vests as to 25% of the shares of Common Stock on the first anniversary of April 29, 2019 and 1/48th of the shares of Common Stock vest each month thereafter for the next 36 months, based on his continued employment by a subsidiary of the Issuer. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:14 UTC |
MCGUIRE TERRANCEDirector
|
PurchaseCommon Stock | 21,635 | $16.00 | $346,160.00 |
DisclosureSEC source: 0001209191-19-024237 · doc4.xml · nonDerivative · entry 2 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Entrepreneurs' Fund VIII, L.P. Disclosed balance after: 21,635 F1 · shares: These shares were acquired from unaffiliated stockholders in a negotiated, private transaction. F3 · ownership.nature: The reportable securities are owned directly by Polaris Entrepreneurs' Fund VIII, L.P. ("PEF VIII"). PPGP VIII is the general partner of PEF VIII. The Reporting Person, a member of the Issuer's Board of Directors, is an interest holder of PPGP VIII. Each of the Reporting Person and the Managing Members, in their respective capacities with respect to PPGP VIII, may be deemed to have shared voting and dispositive power over the shares held by PEF VIII. Each of PPGP VIII, the Reporting Person and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:14 UTC |
MCGUIRE TERRANCEDirector
|
PurchaseCommon Stock | 604,482 | $16.00 | $9,671,712.00 |
DisclosureSEC source: 0001209191-19-024237 · doc4.xml · nonDerivative · entry 1 MCGUIRE TERRANCE · CIK 0001117003 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Partners VIII, L.P. Disclosed balance after: 604,482 F1 · shares: These shares were acquired from unaffiliated stockholders in a negotiated, private transaction. F2 · ownership.nature: The reportable securities are owned directly by Polaris Partners VIII, L.P. ("PP VIII"). Polaris Partners GP VIII, L.L.C. ("PPGP VIII") is the general partner of PP VIII. The Reporting Person, a member of the Issuer's Board of Directors, is an interest holder of PPGP VIII. Each of David Barrett, Brian Chee, Amir Nashat and Bryce Youngren are the managing members of PPGP VIII (collectively, the "Managing Members"). Each of the Reporting Person and the Managing Members, in their respective capacities with respect to PPGP VIII, may be deemed to have shared voting and dispositive power over the shares held by PP VIII. Each of PPGP VIII, the Reporting Person and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:13 UTC |
SCHULMAN AMY WDirector
|
PurchaseCommon Stock | 21,635 | $16.00 | $346,160.00 |
DisclosureSEC source: 0001209191-19-024236 · doc4.xml · nonDerivative · entry 2 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Entrepreneurs' Fund VIII, L.P. Disclosed balance after: 21,635 F1 · shares: These shares were acquired from unaffiliated stockholders in a negotiated, private transaction. F3 · ownership.nature: The reportable securities are owned directly by Polaris Entrepreneurs' Fund VIII, L.P. ("PEF VIII"). PPGP VIII is the general partner of PEF VIII. The Reporting Person, a member of the Issuer's Board of Directors, is an interest holder of PPGP VIII. Each of the Reporting Person and the Managing Members, in their respective capacities with respect to PPGP VIII, may be deemed to have shared voting and dispositive power over the shares held by PEF VIII. Each of PPGP VIII, the Reporting Person and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 08, 2019 Filed Apr 10, 2019 20:13 UTC |
SCHULMAN AMY WDirector
|
PurchaseCommon Stock | 604,482 | $16.00 | $9,671,712.00 |
DisclosureSEC source: 0001209191-19-024236 · doc4.xml · nonDerivative · entry 1 SCHULMAN AMY W · CIK 0001438226 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · By Polaris Partners VIII, L.P. Disclosed balance after: 604,482 F1 · shares: These shares were acquired from unaffiliated stockholders in a negotiated, private transaction. F2 · ownership.nature: The reportable securities are owned directly by Polaris Partners VIII, L.P. ("PP VIII"). Polaris Partners GP VIII, L.L.C. ("PPGP VIII") is the general partner of PP VIII. The Reporting Person, a member of the Issuer's Board of Directors, is an interest holder of PPGP VIII. Each of David Barrett, Brian Chee, Amir Nashat and Bryce Youngren are the managing members of PPGP VIII (collectively, the "Managing Members"). Each of the Reporting Person and the Managing Members, in their respective capacities with respect to PPGP VIII, may be deemed to have shared voting and dispositive power over the shares held by PP VIII. Each of PPGP VIII, the Reporting Person and the Managing Members disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of them is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein. Read SEC document |
| April 02, 2019 Filed Apr 3, 2019 23:42 UTC |
Currie Mark GPresident
|
PurchaseCommon Stock | 270,107 | $14.81 | $4,000,284.67 |
DisclosureSEC source: 0001209191-19-023521 · doc4.xml · nonDerivative · entry 2 Currie Mark G · CIK 0001478244 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 321,755 Read SEC document |
| April 01, 2019 Filed Apr 3, 2019 01:39 UTC |
IRONWOOD PHARMACEUTICALS INC10% owner
|
OtherCommon Stock | 15,562,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-19-019466 · a4.xml · nonDerivative · entry 2 IRONWOOD PHARMACEUTICALS INC · CIK 0001446847 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F2 · kind: Ironwood distributed all of the issued and outstanding shares of Cyclerion common stock to its stockholders on a pro rata basis as part of the separation of Cyclerion from Ironwood into two independent public companies. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.